Virtuix Holdings Inc. VTIX
- Market cap
- $40.4M
- P/E
- 0.0×
Follow VTIX
Target Price Range
Analyst price targets
Free account| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | 0.92 |
Analyst estimates 2027–2029 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | — | 92.74 |
High Price
|
|||
| — | — | — | — | — | — | — | — | — | 39 |
Employees
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | 2 | 4 | 4 |
Revenue
|
|||
| — | — | — | — | — | — | — | 36.59% | (6.33%) | 24.61% |
Gross Margin
|
|||
| — | — | — | — | — | — | — | (12) | (15) | (17) |
EBT
|
|||
| — | — | — | — | — | — | — | (511.39%) | (405.38%) | (392.09%) |
EBT Margin
|
|||
| — | — | — | — | — | — | — | (12) | (15) | (17) |
Net Income
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 4 |
Depreciation
|
|||
| — | — | — | — | — | — | — | 0.38 | 0.44 | 0.18 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | (1.93) | (1.78) | (0.73) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | (1.05) | (0.96) | (0.41) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | (0.17) | (0.06) | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | (1.22) | (1.02) | (0.42) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | 0.22 | (0.10) | 0.13 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | 6 | 8 | 23 |
Shares
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
PS Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 190.37 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | (49.69) | (49.69) | (13.35) |
EV/FCF
|
|||
| — | — | — | — | — | — | — | (7) | (8) | (10) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | (1) | 0 | 0 |
Capex
|
|||
| — | — | — | — | — | — | — | (8) | (8) | (10) |
FCF
|
|||
| — | — | — | — | — | — | — | (1) | (4) | 3 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 2 |
Total Debt
|
|||
| — | — | — | — | — | — | — | 0 | 0 | (7) |
Net Debt
|
|||
| — | — | — | — | — | — | — | 1 | (1) | 3 |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | 0.00% | (275.94%) | (163.61%) |
ROA
|
|||
| — | — | — | — | — | — | — | (543.56%) | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | 0.00% | (5,204.76%) | (1,505.04%) |
ROE
|
|||
Virtuix Holdings Inc. (VTIX) key facts
- Virtuix Holdings Inc.’s revenue for fiscal 2026 (year ended March 2026) was $4.3 million, up 18.4% from fiscal 2025.
- Virtuix Holdings Inc. reported a net loss of $16.8 million, or a loss of $0.73 per share, for fiscal 2026.
- As of September 25, 2026, VTIX traded at $1.17, a market capitalization of $40.4 million.
- Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 9.5× sales.
- Return on equity was −1,505.0% and debt-to-equity -0.35.
Virtuix Holdings Inc. (VTIX) Latest News
23 Sep
Virtuix Holdings announced an expansion of its autism therapy initiative by adding The LP Foundation as a partner to deploy immersive, AI-driven, full-body movement therapy using Omni One. Built on ongoing work with Rutgers University WINLAB and Sirica Therapeutics, the plan calls for a January 2027 multi-site pilot across real-world care settings. Omni One systems will be installed at The LP Foundation’s new enrichment center in New Jersey and at Sirica Therapeutics’ therapy center in the San Francisco Bay Area, with Sirica aiming to build about 100 autism treatment centers nationwide. The initiative taps into a large ABA market (about 12,000 providers) and seeks to demonstrate clinical utility for movement-based therapy. Rutgers has completed the first content-development phase, creating five interactive environments to teach everyday skills like crossing streets and navigating stores. The project signals Virtuix’s expansion of Omni One into healthcare. Expands into autism therapy across multiple centers with potential large-scale deployment if clinically validated.
15 Sep
Virtuix Holdings Inc. sells its first Omni One Systems to the U.S. Department of Veterans Affairs, the largest integrated healthcare system in the U.S. Initial sale to major VA system signals potential new government market access without immediate large-scale revenue impact.
14 Sep
Virtuix Holdings reports 3X growth in Omni One orders with expanding defense and enterprise opportunities. Tripling of orders plus defense and enterprise expansion signals major revenue growth and market strengthening.
8 Sep
Virtuix Holdings Inc. sells first Omni One systems to U.S. Navy’s MWR Liberty Program. Initial Navy sale signals potential for major government contracts and revenue expansion.
5 Sep
Virtuix Holdings (VTIX) stock fair value moves lower as analysts temper Omni One outlook. Lowered fair value estimates from tempered Omni One outlook affect VTIX valuation and short-term sentiment without altering core operations.
2 Sep
Virtuix Holdings Inc. will showcase its AI-enabled counter-drone training system to U.S. Army leaders at the Maneuver Warfighter Conference. Showcase of new system to Army leaders creates moderate potential for future contracts and visibility.
19 Aug
Virtuix Holdings Inc. (VTIX) reported Q1 FY2027 results with Omni One orders rising 150% after Meta launch. 150% order growth after Meta launch signals major revenue upside and trajectory shift for VTIX.
13 Aug
Virtuix Holdings Inc. will showcase accelerating consumer growth plus expansions in defense, robotics and healthcare during the Sidoti Investor Conference. Conference presentation of growth and multi-sector expansion can moderately lift investor visibility without altering core operations or long-term trajectory.
5 Aug
Virtuix Holdings Inc. selects AVRT to advance U.S. Marine Corps Infantry Trainer. Military trainer selection delivers major contract revenue and strategic positioning for Virtuix Holdings Inc.
30 Jul
Virtuix Holdings Inc. lands Tesla as first Omni One enterprise customer, marking major push into humanoid robotics. Landing Tesla as first Omni One customer drives significant expansion in humanoid robotics.
28 Jul
Virtuix Holdings Inc. expands defense business via new U.S. Marine Corps counter-drone training program. Securing U.S. Marine Corps counter-drone program marks major strategic expansion into defense sector.
Virtuix Holdings Inc. enters counter-drone training for the U.S. Marine Corps. Military contract for counter-drone training marks major strategic expansion into defense with strong growth potential.
Virtuix Holdings Inc. (NASDAQ: VTIX) advances AI and robotics strategy with initial sale to Tesla's Optimus Division. Initial sale to Tesla Optimus Division signals major strategic progress likely boosting VTIX market position and investor interest.
27 Jul
Virtuix Holdings Inc. sells its first Omni One Enterprise System to Tesla’s Optimus Robot Division. First enterprise sale to Tesla Optimus signals major validation likely to boost Virtuix revenue prospects and market visibility.
Virtuix Holdings Inc. sold its first enterprise system to Tesla for the Optimus Humanoid Robot Division. First enterprise system sale to Tesla creates major revenue and credibility boost for Virtuix.
23 Jul
Virtuix Holdings Inc. (VTIX) anticipates major sales growth following Meta launch and schedules conference call for first quarter FY2027 results. Major sales growth forecast tied to Meta launch points to significant positive shift in company trajectory and investor sentiment.
21 Jul
Omni One by Virtuix Holdings Inc. wins the XR industry’s top award while the company's AI and humanoid robotics platform gains momentum. Award win and robotics momentum signal major strategic recognition likely to boost VTIX trajectory and sentiment.
16 Jul
Virtuix Holdings Inc. targets expansion through Meta Quest product launch and defense sector training programs. Meta Quest launch combined with defense training focus drives major strategic growth for Virtuix.
15 Jul
Virtuix Holdings Inc. (VTIX) has been selected for NASA’s Moon and Mars Exploration Analog Mission. NASA selection for analog mission boosts credibility and opens aerospace simulation opportunities.
7 Jul
Virtuix Holdings Inc. (VTIX) signed a strategic partnership with Sirica Therapeutics to advance AI-driven autism therapy. Strategic partnership targets AI-driven autism therapy development with potential to boost company trajectory.
2 Jul
Emerging Growth Research reiterates Buy-Emerging rating and $9.00 price target for Virtuix Holdings Inc. following transformational fiscal Q4 2026 results. Analyst buy rating reiteration with price target after strong earnings boosts investor sentiment and stock trajectory.
Virtuix Holdings Inc. will present recent Meta, defense, and financial milestones at the Emerging Growth Conference. Conference presentation of milestones may increase investor visibility and short-term sentiment for VTIX.
1 Jul
Virtuix Holdings Inc. secures first Air National Guard deployment to expand its defense business. First Air National Guard deployment signals entry into defense sector with potential for substantial government contracts.
27 Jun
Virtuix Holdings Inc. (VTIX) explores Meta’s Quest tie-in to advance its XR platform ambitions. Meta Quest tie-in signals major strategic XR move likely to alter Virtuix trajectory and investor views.
Virtuix Holdings Inc. launched the Onni One VR treadmill for Meta Quest users. New product launch targets expanded user base and directly supports company growth.
25 Jun
Virtuix Holdings Inc. reported fiscal year 2026 results, citing Meta launch, defense momentum, and AI initiatives as factors expanding growth opportunities. Meta launch plus defense and AI initiatives represent major strategic moves likely to alter company trajectory and investor sentiment.
23 Jun
Virtuix expands Omni One to Meta Quest, unlocking millions of new users. Expansion to Meta Quest opens access to millions of users and boosts Virtuix market reach.